( allele age |
Canis familiaris |
drug sensitivity |
identity by descent |
P-glycoprotein )
*Veterinary Genetics Laboratory, School of Veterinary Medicine, University of California, Davis, CA 95616;
Edited by Arno G. Motulsky, University of Washington, Seattle, WA, and approved June 22, 2004 (received for review April 3, 2004) A mutation in the canine multidrug resistance gene, MDR1, has previously been associated with drug sensitivities in two breeds from the collie lineage. We exploited breed phylogeny and reports of drug sensitivity to survey other purebred populations that might be genetically at risk. We found that the same allele, mdr1-1
Genetics
Breed distribution and history of canine mdr1-1
, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage
,
,
,
Department of Biostatistics, Johns Hopkins University, Baltimore, MD 21205;
Department of Integrative Biology, University of California, Berkeley, CA 94720; and ¶Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164
, segregated in seven additional breeds, including two sighthounds that were not expected to share collie ancestry. A mutant haplotype that was conserved among affected breeds indicated that the allele was identical by descent. Based on breed histories and the extent of linkage disequilibrium, we conclude that all dogs carrying mdr1-1
are descendants of a dog that lived in Great Britain before the genetic isolation of breeds by registry (ca. 1873). The breed distribution and frequency of mdr1-1
have applications in veterinary medicine and selective breeding, whereas the allele's history recounts the emergence of formally recognized breeds from an admixed population of working sheepdogs.
To whom correspondence should be addressed.
www.pnas.org/cgi/doi/10.1073/pnas.0402374101
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg What's this?
This article has been cited by other articles in HighWire Press-hosted journals:
![]() |
Y. Kitamura, H. Koto, S. Matsuura, T. Kawabata, H. Tsuchiya, H. Kusuhara, H. Tsujimoto, and Y. Sugiyama Modest Effect of Impaired P-glycoprotein on the Plasma Concentrations of Fexofenadine, Quinidine, and Loperamide following Oral Administration in Collies Drug Metab. Dispos., May 1, 2008; 36(5): 807 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. G. Parker, A. V. Kukekova, D. T. Akey, O. Goldstein, E. F. Kirkness, K. C. Baysac, D. S. Mosher, G. D. Aguirre, G. M. Acland, and E. A. Ostrander Breed relationships facilitate fine-mapping studies: A 7.8-kb deletion cosegregates with Collie eye anomaly across multiple dog breeds Genome Res., November 1, 2007; 17(11): 1562 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Thamm and D. M. Vail Aftershocks of Cancer Chemotherapy: Managing Adverse Effects J. Am. Anim. Hosp. Assoc., January 1, 2007; 43(1): 1 - 7. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Pires, L. Ouragh, M. Kalboussi, J. Matos, F. Petrucci-Fonseca, and M. W. Bruford Mitochondrial DNA Sequence Variation in Portuguese Native Dog Breeds: Diversity and Phylogenetic Affinities J. Hered., July 1, 2006; 97(4): 318 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Clark, J. M. Wahl, C. A. Rees, and K. E. Murphy From The Cover: Retrotransposon insertion in SILV is responsible for merle patterning of the domestic dog PNAS, January 31, 2006; 103(5): 1376 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Ostrander and R. K. Wayne The canine genome Genome Res., December 1, 2005; 15(12): 1706 - 1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. K. Puja, D. N. Irion, A. L. Schaffer, and N. C. Pedersen The Kintamani Dog: Genetic Profile of an Emerging Breed from Bali, Indonesia J. Hered., November 1, 2005; 96(7): 854 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
Vet. Pathol., November 1, 2004; 41(6): 712 - 712. [Full Text] [PDF] |
||||